FDA Brief

Warning letters Food

FDA warning letter to

11-11-11 Brands

High riskIssued Nov 16, 2022Posted Nov 21, 2022Center for Food Safety and Applied Nutrition (CFSAN)

FDA warned 11-11-11 Brands that its Mood33 Hemp Infused Herbal Teas contain added CBD, an unapproved food additive that makes them adulterated.

What happened

In October 2022 FDA reviewed the company's website, mood33.com, which is listed on the product label, and collected and analyzed a sample of the product. The sample confirmed CBD was present, yet the label did not list CBD as an ingredient. FDA also noted that the Joy Peach-Yerba Mate and Energy Raspberry Lemon-Guayusa-Green Tea varieties appear to contain caffeine, and that CBD may increase or prolong caffeine's effects.

What FDA found

  1. Adding CBD to a regular food makes it an unsafe food additive, because CBD has no FDA approval for use in food and is not generally recognized as safe.

    FD&C Act sections 402(a)(2)(C)(i) and 409, 21 U.S.C. 342(a)(2)(C)(i) and 348
  2. Shipping these teas across state lines is a prohibited act.

    FD&C Act section 301(a), 21 U.S.C. 331(a)
  3. CBD is the active ingredient in an approved drug and has been the subject of public clinical investigations, so adding it to food is separately prohibited.

    FD&C Act section 301(ll), 21 U.S.C. 331(ll)
  4. The label does not list CBD as an ingredient, so consumers may not know they are consuming it.

  5. The teas are in a drink form that consumers may confuse with traditional foods, creating a risk of unintended CBD consumption.

What FDA wants

FDA asks the company to write within fifteen working days describing the specific steps taken to correct the violations and prevent recurrence, with supporting documents, or to explain why it believes the products are not in violation. The response goes to CFSANResponse@fda.hhs.gov with "CMS 627690" in the subject line.

Who should pay attention

  • beverage and tea brands adding hemp or CBD to drinks
  • co-packers and contract manufacturers that produce CBD-infused beverages
  • retailers and distributors selling CBD-containing foods

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Trew Balance

    FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  2. Bailey’s Wellness, LLC dba Bailey’s CBD

    Bailey’s CBD markets CBD animal and human products with unapproved drug claims, including products for food-producing animals.

    High risk
  3. House of Alchemy LLC dba CBD Dog Health Hamet & Love LLC dba MycoDog

    FDA warned CBD Dog Health and MycoDog their CBD and mushroom pet products are unapproved animal drugs, citing disease-treatment claims online.

    High risk
  4. Holista LLC dba HolistaPet

    FDA warned HolistaPet that its CBD animal products are unapproved new animal drugs and adulterated animal food.

    High risk